Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 39.17% vs 22.03% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 248.19% vs 29.66% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 262.60% vs -161.70% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 17.07% vs 78.26% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Genpharmasec With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 39.17% vs 22.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 295.65% vs 37.35% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 248.19% vs 29.66% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 555.56% vs 0.00% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 262.60% vs -161.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 300.00% vs -9,900.00% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 17.07% vs 78.26% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 336.36% vs -31.25% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






